Cost-Effectiveness Data and Pricing of Icosapent Ethyl

Dr Mark Fendrick Explains Bipartisan Appeal of Value-Based Insurance Design

Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain

Dr Peter McAllister Shares How COVID-19 Altered Patients' Migraine Symptoms

Dr Stephen Silberstein Discusses Erenumab Use for Menstrual Migraine

Dr Ruth Ann Marrie Discusses Comorbidities in Multiple Sclerosis

Dr George Bakris Compares FIDELIO-DKD Renal Outcomes With Those of SGLT-2 Inhibitor Trials

Dr Shweta Bansal Explains Factors Associated With Increased Screening, Recognition of CKD

Dr Joshua Rein Offers Insights on Cannabis Use for Chronic Kidney Disease

Akebia Therapeutics' CEO on Mechanisms of HIF-PHI Candidate

Dr Rajiv Agarwal Discusses Finerenone, Results of FIDELIO-DKD

Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors

Whole-Person Health Care: Integrating Mental and Behavioral Health Into Primary Care

A Patient Perspective on Early-Onset Parkinson Disease

Dr Stephen Silberstein Compares the Effects of Erenumab on Chronic, Episodic Migraine

Dr Frank Porreca Discusses New Developments in Migraine Science

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

Dr Neal Jain Discusses Type 2 Inflammation in Asthma

Dr Kassandra Munger on Vitamin D and Multiple Sclerosis

Dr Timothy Yap: Rucaparib/Sacituzumab Govitecan Combo Effective Against Triple-Negative Disease

Dr Neal Jain on the Real-World Results of Dupilumab in Asthma

Using SGLT2 Inhibitors to Achieve Cardiovascular Benefits

Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC

Cost-Effectiveness Data and Pricing of Icosapent Ethyl

Dr John McMurray Compares EMPEROR-Reduced Findings with DAPA-HF